Nanjing Vazyme Biotech Co Ltd (688105) — Financial Flexibility Index
Nanjing Vazyme Biotech Co Ltd (688105) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥91.13 Million (operating CF CN¥75.30 Million minus capex CN¥15.83 Million) represents 0% of total liabilities (CN¥1.17 Billion). Check 688105 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nanjing Vazyme Biotech Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Nanjing Vazyme Biotech Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Nanjing Vazyme Biotech Co Ltd generate cash.
Annual Financial Flexibility Index for Nanjing Vazyme Biotech Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Nanjing Vazyme Biotech Co Ltd. Explore Nanjing Vazyme Biotech Co Ltd (688105) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | CN¥280.54 Million | CN¥233.16 Million | CN¥1.24 Billion | ▲ +284.4% |
| 2024 | 0.06x | CN¥65.21 Million | CN¥-9.68 Million | CN¥1.11 Billion | ▼ -76.5% |
| 2023 | 0.25x | CN¥431.31 Million | CN¥198.40 Million | CN¥1.72 Billion | ▼ -79.4% |
| 2022 | 1.22x | CN¥1.70 Billion | CN¥735.17 Million | CN¥1.39 Billion | ▼ -33.4% |
| 2021 | 1.83x | CN¥878.76 Million | CN¥616.80 Million | CN¥479.83 Million | ▼ -46.5% |
| 2020 | 3.42x | CN¥956.10 Million | CN¥803.55 Million | CN¥279.28 Million | ▲ +1113.1% |
| 2019 | 0.28x | CN¥35.08 Million | CN¥15.20 Million | CN¥124.31 Million | ▼ -15.1% |
| 2018 | 0.33x | CN¥28.13 Million | CN¥-4.00 Million | CN¥84.67 Million | ▼ -16.5% |
| 2017 | 0.40x | CN¥14.96 Million | CN¥-3.86 Million | CN¥37.57 Million | — |